Menopausal Disorder Treatment Industry Outlook 2025-2029: Market Set to Cross $15.2 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Menopausal Disorder Treatment Market Size By 2025?
The market for treating menopausal disorders has seen significant growth in recent times, with projections indicating an increase from $10.69 billion in 2024 to $11.47 billion in 2025, following a compound annual growth rate (CAGR) of 7.3%. The expansion during the historical period is accredited to the maturing female population, heightened understanding of health concerns related to menopause, rising incidence of obesity which worsens menopausal symptoms, increased adoption of hormone replacement therapy (HRT), and the emergence of personalized medicine.

How Big Is the Menopausal Disorder Treatment Market Size Expected to Grow by 2029?
The market for menopausal disorder treatments is predicted to witness substantial expansion in the coming years, escalating to "$15.2 billion by 2029 with a compound annual growth rate (CAGR) of 7.3%. This projected upsurge within the forecasted period can be credited to increased spending on healthcare infrastructure, the rising focus on women's health schemes, accelerating partnerships between pharmaceutical corporations and research bodies, and the swell of urbanization that leads to lifestyle modifications affecting menopausal health. Key trends identified for the forecasted duration encompass a move towards organic and herbal therapies, the inclusion of artificial intelligence in treatment formulation, the proliferation of wearable technology for on-te-spot symptom tracking, an emphasis on inclusive wellness programs pertaining to menopause, and the proliferation of investments in startups dedicated to solutions for menopause in women's health.

View the full report here:
https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

Which Key Market Drivers Powering Menopausal Disorder Treatment Market Expansion and Growth?
The enhanced interest in hormone replacement therapies (HRT) is anticipated to spur the expansion of the menopausal disorder treatment market in the future. Hormone replacement therapy is a medical procedure that supplements or substitutes hormones to mitigate the complications linked with menopause or hormonal imbalances. The demand for HRTs is fueled by the escalating awareness and need for efficient management of symptoms related to menopause and hormonal imbalances. By directly boosting estrogen and progesterone levels, hormone replacement therapies treat menopausal disorder, aid in reinstating hormonal equilibrium and relieve disruptive signs such as hot flashes, night sweats, and mood swings, eventually enriching the quality of life. In October 2024, for instance, NHS Business Services Authority (NHSBSA), a UK-based entity rendering numerous support services, disclosed a rise in the number of HRT items prescribed by 22% to 13 million, in conjunction with a 12% surge in identified patients from 2.3 million in 2022/23 to 2.6 million in 2023/24. Therefore, the escalating demand for hormone replacement therapies is catalyzing the expansion of the menopausal disorder treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Menopausal Disorder Treatment Market?
Leading firms in the menopausal disorder treatment market are working on the creation of inventive nonhormonal neurokinin 3 (NK3) receptor antagonist medicines aimed at managing vasomotor symptoms without the need for hormonal therapy. These pioneering nonhormonal neurokinin 3 (NK3) receptor antagonist treatments are new types of therapies that block NK3 receptors with the goal of handling menopausal symptoms without the use of hormones. For instance, Astellas Pharma Inc., a pharmaceutical company based in Japan, obtained approval from the European Commission in December 2023 for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist designed to treat moderate to severe vasomotor symptoms (VMS) like hot flashes and night sweats experienced by menopausal women. The drug achieves this by focusing on neurons in the brain's temperature control center, thus reducing both the frequency and severity of these symptoms.

What Are the Emerging Segments in the Menopausal Disorder Treatment Market?
The menopausal disorder treatment market covered in this report is segmented -

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications
2) By Stages: Menopause, Postmenopause, Perimenopause
3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets
2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements
3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed
4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

Who Are the Global Leaders in the Menopausal Disorder Treatment Market?
Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.

Which are the Top Profitable Regional Markets for the Menopausal Disorder Treatment Industry?
North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24318

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.